Cargando…
Novel Cyclopentaquinoline and Acridine Analogs as Multifunctional, Potent Drug Candidates in Alzheimer’s Disease
A series of new cyclopentaquinoline derivatives with 9-acridinecarboxylic acid and a different alkyl chain length were synthesized, and their ability to inhibit cholinesterases was evaluated. All designed compounds, except derivative 3f, exhibited a selectivity for butyrylcholinesterase (BuChE) with...
Autores principales: | Maciejewska, Karolina, Czarnecka, Kamila, Kręcisz, Paweł, Niedziałek, Dorota, Wieczorek, Grzegorz, Skibiński, Robert, Szymański, Paweł |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179981/ https://www.ncbi.nlm.nih.gov/pubmed/35682556 http://dx.doi.org/10.3390/ijms23115876 |
Ejemplares similares
-
New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer’s disease
por: Czarnecka, Kamila, et al.
Publicado: (2017) -
Discovery of New Cyclopentaquinoline Analogues as Multifunctional Agents for the Treatment of Alzheimer’s Disease
por: Czarnecka, Kamila, et al.
Publicado: (2019) -
New cyclopentaquinoline and 3,5-dichlorobenzoic acid hybrids with neuroprotection against oxidative stress for the treatment of Alzheimer’s disease
por: Czarnecka, Kamila, et al.
Publicado: (2023) -
New Tetrahydroacridine Hybrids with Dichlorobenzoic Acid Moiety Demonstrating Multifunctional Potential for the Treatment of Alzheimer’s Disease
por: Czarnecka, Kamila, et al.
Publicado: (2020) -
Correction to: New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer’s disease
Publicado: (2018)